Evidence map›Paper›PMID 35962651›Full record

ArticlePsychiatry and clinical neurosciences2022

Proportion of subjects with psychotic features in bipolar disorder correlated with treatment response by antipsychotics for acute mania.

Masashi Ikeda, Takeo Saito, Tetsufumi Kanazawa, Taro Kishi, Nakao Iwata

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Psychiatry and clinical neurosciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Masashi IkedaDepartment of Psychiatry, Fujita Health University School of Medicine, Toyoake, Japan.ORCID 0000-0001-6237-2449
Takeo SaitoDepartment of Psychiatry, Fujita Health University School of Medicine, Toyoake, Japan.
Tetsufumi KanazawaDepartment of Neuropsychiatry, Osaka Medical College, Takatsuki, Japan.
Taro KishiDepartment of Psychiatry, Fujita Health University School of Medicine, Toyoake, Japan.ORCID 0000-0002-9237-2236
Nakao IwataDepartment of Psychiatry, Fujita Health University School of Medicine, Toyoake, Japan.

Funding

GRIFIN of P3GM from the Japan Agency for Medical Research and Development JP20km0405201GRIFIN of P3GM from the Japan Agency for Medical Research and Development JP20km0405208GRIFIN of P3GM from the Japan Agency for Medical Research and Development JP21tm0424220Health and Labor Sciences Research 21GC1018Japan Agency for Medical Research and Development JP22dk0307107JSPS Kakenhi JP19K08082JSPS Kakenhi JP21H02854JSPS Kakenhi JP21K07490Private University Research Branding Project from MEXTSRPBS from the Japan Agency for Medical Research and Development JP20dm0107097SRPBS from the Japan Agency for Medical Research and Development JP22wm0425008SRPBS from the Japan Agency for Medical Research and Development JP22wm0525024
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antipsychotic AgentsBipolar DisorderPsychotic DisordersHumansManiaOlanzapineRisperidoneAntipsychotic AgentsOlanzapineRisperidone

Identifiers

PMID35962651
PMCPMC9826388

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.